US FDA grants approval of Moderna’s Covid-19 vaccine in adults under Emergency Use Authorization

Approval was based on an analysis of 28,207 US subjects enrolled in an ongoing placebo-controlled RCT. The vaccine was reported to be 94.1% effective in preventing COVID-19 disease with 11 cases of COVID-19 in the vaccine group and 185 in the placebo group after two doses.

FDA